A Safety Study of SGN-35T in Adults With Advanced Cancers

Conditions: Lymphoma, T-Cell, Cutaneous; Hodgkin Disease; Lymphoma, T-Cell, Peripheral; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin Interventions: Drug: SGN-35T Sponsors: Seagen Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials